3Cascinus S, Catalano V, Giordani P, et al. Gastrointestnal cancer refractory to chemotherapy: A role for Octreotide[J]. Arch Dis Child, 2001,47(2) : 127-133.
5Halkic N, Abdelmoumene A, Suardet L, etal. Postoperative chylous ascites after radical gastrectomy: a case report[J]. Mi- nerva Chir,2003,58(3) :389-391.
二级参考文献5
1Kaas R, Rustman LD, Zoetmulder FAN. Chylous ascites after oncological abdominal surgery:incidenece and treatment. Eur J Sury Onco1,2001,27 :187-189.
2Halkic N, Abdelmoumene A, Suardet L, et al. Postoperative chylous ascites after radical gastrectomy: a case report. Minerva Chir,2003,58:389-391.
3Tsimoyiannis EC, Jabarin M, Tsimoyiannis JC, et al. Ultrasonically activated shears in extended lymphadenectomy for gastric cancer.Word J Surg,2002,26:158-161.
4Bhatia C, Pratap U, Slavik Z. Octreotide therapy:a new horizon in treatment of iatrogenic chyloperitoneum. Arch Dis Child, 2001,85:234-235.
5Beltrami EM, Williams IT, Shapiro CN, et al. Risk and manage - ment of blood - borne infections in health care workers [ J ]. Clini- cal Microbiology,2000,13(3) : 385.
